Atlanta, Georgia – A major international investment is set to reshape Georgia’s life sciences landscape, as state leaders confirmed plans for a new pharmaceutical manufacturing facility backed by a $2 billion commitment. The project signals a significant step forward for both the state’s economy and its growing role in advanced medical innovation.
The announcement outlines plans for a large-scale biologics manufacturing site to be developed in Gwinnett County at the Rowen campus, a 2,000-acre hub designed to bring together research, education, and industry. Over the coming years, the initiative is expected to create 330 new jobs, adding to the region’s expanding workforce in the life sciences sector.
State officials framed the development as the result of ongoing collaboration, pointing to earlier discussions with company leadership that helped position Georgia as a strategic partner. The investment stands among the largest in the state’s history and reinforces its ambitions to become a center for cutting-edge biomedical work…